Myasthenia Gravis Foundation of America (MGFA™), the largest, leading patient advocacy organization in the United States solely dedicated to the myasthenia gravis (MG) community, announced the ...

Jonathan Strober, MD, explains the initial presentation of myasthenia gravis in a pediatric patient population and why initial diagnosis for these patients can be challenging. Jonathan Strober, MD ...

Cartesian Therapeutics enrolls first participant in Phase 3 trial of Descartes-08 for myasthenia gravis treatment. Quiver AI Summary. Cartesian Therapeutics, Inc. has announced the enrollment of ...

YANTAI, China, May 27, 2025 /PRNewswire/ -- On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National ...

Myasthenia gravis with hyperthyroidism and exophthalmic goiter has been reported. Eaton is quoted by McEachern and Parnell 2 as stating that 6 per cent of myasthenic patients studied at the Mayo ...

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND ...

Evidence-based recommendations on efgartigimod (Vyvgart) for treating antibody-positive generalised myasthenia gravis in adults.. Last reviewed: 04 June 2025 Next review: This guidance will be ...

We identified significant germline mutations in the DUOX2 gene (approximately 8.8%), commonly associated with congenital hypothyroidism and thyroid dyshormonogenesis, and found these mutations to ...

Last year, the FDA placed a partial clinical hold on tolebrutinib phase 3 trials in MS and myasthenia gravis after cases of drug-induced liver injury were observed, with recruitment of new studies ...

The UK regulatory authority has cleared the path for some patients with generalised myasthenia gravis (gMG) to get early access to Argenx' efgartigimod while it reviews the marketing application ...

A European sperm donor linked to 67 pregnancies carried a rare cancer-causing mutation, reportedly leading to cancer in 10 children and raising concerns about genetic screening limits.